This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Basun, H., Grut, M., Winblad, B. and Lannfelt, L. (1995), “Apolipoprotein ε4 allele and disease progression in patients with late-onset Alzheimer’s disease.” Neuroscience Letters. 183:32–34.
Basun, H., Corder, E.H., Guo, Z., Lannfelt, L., Corder, L.S., Manton, K.G., Winblad, B. and Viitanen, M. (1996), “Apolipoprotein E polymorphism and stroke in a population sample age 75+.” Stroke, 27:1310–1315.
Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A. (1993), “Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families.” Science, 261:921–923.
Corder, E.H., Saunders, A.M., Strittmatter, W.J., Risch, N.J., Schmechel, D.E., Gaskell, P.C., Rimmler, J.B. and Locke, P.A. (1994), “Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.” Nature Genetics, 169:175–184.
Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C. Jr., Rimmler, J.B., Locke, P.A., Conneally, P.M., Schmader, K.E. and Tanzi, R.E. (1995), “Apolipoprotein E, survival in Alzheimer disease patients, and the competing risks of death and Alzheimer disease.” Neurology, 45:1323–1328.
Corder, E.H., Lannfelt, L., Viitanen, M., Corder, L.S., Manton, K.G., Winblad, B. and Basun, H. (1996), “Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition.” Archives of Neurology, 53:418–422.
Corder, E.H., Ervin, J.F., Lockhart, E., Szymanski, M.H., Schmechel, D.E. and Hulette, C.M. (2005), “Cardiovascular damage in Alzheimer disease: autopsy findings from the Bryan ADRC.” J. Biomed. Biotechnol. 2005 (2):189–197.
Dal Forno, G., Rasmusson, X., Brandt, J., Carson, K.A., Brookmeyer, R., Troncoso, J. and Kawas, C.H. (1996), “Apolipoprotein E genotype and rate of decline in probable Alzheimer’s disease.” Archives of Neurology, 53:345–350.
Davignon, J., Gregg, R.E. and Sing, C.F. (1988), “Apolipoprotein E polymorphism and atherosclerosis.” Arteriosclerosis, 8:1–12.
Ervin, J.F., Pannell, C., Szymanski, M., Welsh-Bohmer, K., Schmechel, D.E. and Hulette, C.M. (2004), “Vascular smooth muscle actin is reduced in Alzheimer disease brain: a quantitative analysis.” Journal of Neuropathology & Experimental Neurology, 63(7):735–741.
Folstein, M.F., Folstein, S.E. and McHugh, P.R. (1975), “Mini mental state: a practical method for grading the cognitive state of patients for the clinician.” Journal of Psychiatric Research, 12:189–198.
Fratiglioni, L., Grut, M., Forsell, Y., Viitanen, M., Grafstrom, M., Holmen, K., Ericsson, K., Backman, L., Ahlbom, A. and Winblad, B. (1991), “Prevalence of Alzheimer’s disease in an elderly urban population: relationship with age, sex, and education.” Neurology 41:1886–1892.
Fratiglioni, L., Viitanen, M., Bäckman, L., Sandman, P.-O. and Winblad, B. (1992), “Occurrence of dementia in advanced age: the study design of the Kungsholmen Project.” Neuroepidemiology, 1:29–36.
Kalaria, R.N. and Premkumar, D.R.D. (1995), “Apolipoprotein E genotype and cerebral amyloid angiopathy.” Lancet, 346:1424.
Kaplan, E.L. and Meier, P. (1958), “Nonparametric estimation from incomplete observations.” Journal of the American Statistical Association, 53:457–481.
Kuusisto, J., Koivisto, K., Kervinen, K., Mykkanen, L., Helkala, E.L., Vanhanen, M., Hanninen, T., Pyorala, K., Kesaniemi, Y.A. and Riekkinen, P. (1994), “Association of apolipoprotein E phenotypes with late onset Alzheimer’s disease: population based study.” British Medical Journal, 309:636–638.
Louhija, J., Miettinen, H.E., Kontula, K., Tikkanen, M.J., Miettinen, T.A. and Tilvis, R.S. (1994), “Aging and genetic variation of plasma apolipoproteins: relative loss of the apolipoprotein E4 phenotype in centenarians.” Arteriosclerosis and Thrombosis, 14:1084–1089.
Norrman, J., Brookes, A.J., Yates, C. and St Clair, D. (1995), “Apolipoprotein E genotype and its effect on duration and severity of early and late onset Alzheimer’s disease.” British Journal of Psychiatry, 167:533–536.
Peto, R., Pike, M.C., Armitage, P., Breslow, N.E., Cox, D.R., Howard, S.V., Mantel, N., McPherson, K., Peto, J. and Smith, P.G. (1977), “Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples.” British Journal of Cancer, 35:1–39.
Salloway, S., Gur, T., Berzin, T., Tavares, R., Zipser, B., Correia, S., Hovanesian, V., Fallon, J., Kuo-Leblanc, V., Glass, D., Hulette, C., Rosenberg, C., Vitek, M., Stopa, E. (2002), “Effect of APOE genotype on microvascular basement membrane in Alzheimer’s disease.” Journal of the Neurological Sciences, 203–204:183–187.
SAS Institute. (1988), “The lifetest procedure.” SAS Technical Report P-179, Additional SAS/STAT Procedures, Version 6.03, SAS Institute, Cary, pp. 49–89, 519–640.
Saunders, A.M., W.J. Strittmatter, W.J., Schmechel, D.E., George-Hyslop, P.H., Pericak-Vance, M.A., Joo, S.H., Rosi, B.L., Gusella, J.F., Crapper-MacLachlan, D.R. and Alberts, M.J. (1993), “Association of apolipoprotein E allele ε4 with late onset familial and sporadic Alzheimer’s disease.” Neurology, 43:1467–1472.
Schächter, F., Faure-Delanef, L., Guenot, F., Rouger, H., Froguel, P., Lesueur-Ginot, L., Cohen D., (1994), “Genetic associations with human longevity at the APOE and ACE loci.” Nature Genetics, 6:29–32.
Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S. and Roses, A.D. (1993), “Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type ε4 allele in late-onset familial Alzheimer disease.” Proceedings of the National Academy of Science USA, 90:1977–1981.
Utermann, G., Hardewig, A. and Zimmer (1984), “Apolipoprotein E phenotypes in patients with myocardial infarction.” Human Genetics, 65:237–241.
WHO (World Health Organization). (1977), International Classification of Diseases 1975, Revision. Vol. 1. WHO: Geneva.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer
About this chapter
Cite this chapter
Corder, E.H., Lannfelt, L., Viitanen, M., Corder, L.S., Winblad, B. (2006). Does Apolipoprotein E Polymorphism Determine the Survivability of Vascular Accidents at Advanced Ages? Implications for Mortality Differentials. In: Yi, Z., Crimmins, E.M., Carrière, Y., Robine, JM. (eds) Longer Life and Healthy Aging. International Studies in Population, vol 2. Springer, Dordrecht. https://doi.org/10.1007/1-4020-4032-6_10
Download citation
DOI: https://doi.org/10.1007/1-4020-4032-6_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-4024-5
Online ISBN: 978-1-4020-4032-0
eBook Packages: MedicineMedicine (R0)